These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
435 related articles for article (PubMed ID: 34309078)
1. European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II. Schmidt E; Rashid H; Marzano AV; Lamberts A; Di Zenzo G; Diercks GFH; Alberti-Violetti S; Barry RJ; Borradori L; Caproni M; Carey B; Carrozzo M; Cianchini G; Corrà A; Dikkers FG; Feliciani C; Geerling G; Genovese G; Hertl M; Joly P; Meijer JM; Mercadante V; Murrell DF; Ormond M; Pas HH; Patsatsi A; Rauz S; van Rhijn BD; Roth M; Setterfield J; Zillikens D; C Prost ; Zambruno G; Horváth B; Caux F J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):1926-1948. PubMed ID: 34309078 [TBL] [Abstract][Full Text] [Related]
2. European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I. Rashid H; Lamberts A; Borradori L; Alberti-Violetti S; Barry RJ; Caproni M; Carey B; Carrozzo M; Caux F; Cianchini G; Corrà A; Diercks GFH; Dikkers FG; Di Zenzo G; Feliciani C; Geerling G; Genovese G; Hertl M; Joly P; Marzano AV; Meijer JM; Mercadante V; Murrell DF; Ormond M; Pas HH; Patsatsi A; Prost C; Rauz S; van Rhijn BD; Roth M; Schmidt E; Setterfield J; Zambruno G; Zillikens D; Horváth B J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):1750-1764. PubMed ID: 34245180 [TBL] [Abstract][Full Text] [Related]
3. Mucous membrane pemphigoid. Du G; Patzelt S; van Beek N; Schmidt E Autoimmun Rev; 2022 Apr; 21(4):103036. PubMed ID: 34995762 [TBL] [Abstract][Full Text] [Related]
4. A Case of Anti-BP180-type Mucous Membrane Pemphigoid with IgG and IgA Autoantibodies Showing Distinct Reactivities. Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Nakazawa M; Sawamura D Acta Dermatovenerol Croat; 2022 Jul; 30(1):54-56. PubMed ID: 36153720 [TBL] [Abstract][Full Text] [Related]
5. Symmetrical Skin Lesions on the Gluteal Region in a Patient with Anti-Laminin-332 Mucous Membrane Pemphigoid. Maki N; Demitsu T; Nagato H; Okada O; Yoneda K; Hashimoto T; Hasunuma N; Osada I; Manabe M Acta Dermatovenerol Croat; 2021 Jul; 29(2):105-107. PubMed ID: 34477077 [TBL] [Abstract][Full Text] [Related]
6. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity. Oyama N; Setterfield JF; Powell AM; Sakuma-Oyama Y; Albert S; Bhogal BS; Vaughan RW; Kaneko F; Challacombe SJ; Black MM Br J Dermatol; 2006 Jan; 154(1):90-8. PubMed ID: 16403100 [TBL] [Abstract][Full Text] [Related]
7. Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV). Borradori L; Van Beek N; Feliciani C; Tedbirt B; Antiga E; Bergman R; Böckle BC; Caproni M; Caux F; Chandran NS; Cianchini G; Daneshpazhooh M; De D; Didona D; Di Zenzo GM; Dmochowski M; Drenovska K; Ehrchen J; Goebeler M; Groves R; Günther C; Horvath B; Hertl M; Hofmann S; Ioannides D; Itzlinger-Monshi B; Jedličková J; Kowalewski C; Kridin K; Lim YL; Marinovic B; Marzano AV; Mascaro JM; Meijer JM; Murrell D; Patsatsi K; Pincelli C; Prost C; Rappersberger K; Sárdy M; Setterfield J; Shahid M; Sprecher E; Tasanen K; Uzun S; Vassileva S; Vestergaard K; Vorobyev A; Vujic I; Wang G; Wozniak K; Yayli S; Zambruno G; Zillikens D; Schmidt E; Joly P J Eur Acad Dermatol Venereol; 2022 Oct; 36(10):1689-1704. PubMed ID: 35766904 [TBL] [Abstract][Full Text] [Related]
8. Case Report: Mucous Membrane Pemphigoid With IgG and IgA Anti-Laminin γ1 Antibodies and IgA Anti-Laminin α5 Antibodies. Kuang W; Qian H; Zhang Q; Li W; Hashimoto T; Zeng X; Li X Front Immunol; 2022; 13():903174. PubMed ID: 35720393 [TBL] [Abstract][Full Text] [Related]
9. Autoantibody Detection for Diagnosis in Direct Immunofluorescence-Negative Mucous Membrane Pemphigoid: Ocular and Other Sites Compared. Dart J; Setterfield J; Groves RW; Mee JB; Diercks GFH; Pas HH; Minassian D; Ophthalmology; 2021 Mar; 128(3):372-382. PubMed ID: 32745569 [TBL] [Abstract][Full Text] [Related]
10. Case report: Mucous membrane pemphigoid with complicated autoantibody profile indicating the necessity of comprehensive diagnostic methods and the contribution of IgA autoantibodies. Liu W; Li H; Jin Y; Cheng L; Shi L; Gao Y; Zhou Z; Feng S; Qian H; Hashimoto T; Li X Front Immunol; 2023; 14():1149119. PubMed ID: 36969205 [TBL] [Abstract][Full Text] [Related]
11. Disease Endotypes Predict the Severity of Mucous Membrane Pemphigoid. Fairley JA; Crowe TP; Fakhimi M; Palmer SJ; Greiner MA; Hellstein JW; Van Daele DJ; Messingham KN J Invest Dermatol; 2023 Aug; 143(8):1479-1486.e3. PubMed ID: 36870557 [TBL] [Abstract][Full Text] [Related]
12. Development of pemphigus foliaceus in a mucous membrane pemphigoid patient: An insight into possible mechanism eliciting a distinct autoimmune bullous disease in a rare anti-basement membrane autoimmunity. Shimoda-Komatsu Y; Fukui K; Yamazaki Y; Ohyama M J Dermatol; 2021 May; 48(5):710-714. PubMed ID: 33725421 [TBL] [Abstract][Full Text] [Related]
13. Detection of linear IgE deposits in bullous pemphigoid and mucous membrane pemphigoid: a useful clue for diagnosis. Yayli S; Pelivani N; Beltraminelli H; Wirthmüller U; Beleznay Z; Horn M; Borradori L Br J Dermatol; 2011 Nov; 165(5):1133-7. PubMed ID: 21711326 [TBL] [Abstract][Full Text] [Related]
15. Insights into clinical and diagnostic findings as well as treatment responses in patients with mucous membrane pemphigoid: A retrospective cohort study. Rashid H; Meijer JM; Bolling MC; Diercks GFH; Pas HH; Horváth B J Am Acad Dermatol; 2022 Jul; 87(1):48-55. PubMed ID: 34896128 [TBL] [Abstract][Full Text] [Related]
16. The Second Study of Clinical and Immunological Findings in Anti-laminin 332-Type Mucous Membrane Pemphigoid Examined at Kurume University-Diagnosis Criteria Suggested by Summary of 133 Cases. Qian H; Natsuaki Y; Koga H; Kawakami T; Tateishi C; Tsuruta D; Ishii N; Li X; Hashimoto T Front Immunol; 2021; 12():771766. PubMed ID: 34899722 [TBL] [Abstract][Full Text] [Related]
17. [Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept®)]. Raffin D; Delaplace M; Roussel A; Estève E Ann Dermatol Venereol; 2013 Dec; 140(12):784-7. PubMed ID: 24315224 [TBL] [Abstract][Full Text] [Related]
18. Immune-mediated subepithelial blistering diseases of mucous membranes. Pure ocular cicatricial pemphigoid is a unique clinical and immunopathological entity distinct from bullous pemphigoid and other subsets identified by antigenic specificity of autoantibodies. Chan LS; Yancey KB; Hammerberg C; Soong HK; Regezi JA; Johnson K; Cooper KD Arch Dermatol; 1993 Apr; 129(4):448-55. PubMed ID: 7682049 [TBL] [Abstract][Full Text] [Related]
19. Mucous membrane pemphigoid with generalized blisters: IgA and IgG autoantibodies target both laminin-332 and type XVII collagen. Hayashi I; Shinkuma S; Shimizu S; Natsuga K; Ujiie H; Yasui C; Tsuchiya K; Nishie W; Shimizu H Br J Dermatol; 2012 May; 166(5):1116-20. PubMed ID: 22182184 [TBL] [Abstract][Full Text] [Related]
20. Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita - Brazilian Society of Dermatology. Santi CG; Gripp AC; Roselino AM; Mello DS; Gordilho JO; Marsillac PF; Porro AM An Bras Dermatol; 2019 Apr; 94(2 Suppl 1):33-47. PubMed ID: 31166405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]